77% of retail investor accounts lose money when trading CFDs with this provider.
77% of retail investor accounts lose money when trading CFDs with this provider.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
77% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
77% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
GlaxoSmithKline is a British pharmaceutical company headquartered in London. The company develops, manufactures and markets vaccines and medicines and health related consumer products. GSK has more than 80 manufacturing facilities in 36 countries. The US and Europe account for around 61% of revenues.
The company is limited on the London Stock Exchange and is a component of the FTSE 100 and has a secondary listing on the New York Stock Exchange.